Table 2.
Characteristics of patients with power morcellated uterine leiomyosarcoma (40 patients from 14 studies)
| Author | n | Initial operation | Tumor size (cm) | Uterine weight (g) | Re-exploration surgery | Final stage | Adjuvant | Recurrence | Site of recurrence | RFS (mon) | Follow-up time (month) | Final status |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tan-Kim et al., 2015[11] | 1 | LSH BSO | 5 | 285 | Y: Trachelectomy | I | N | NR | - | - | 31 | NED |
| 2 | LSH | NR | 486 | Y: BSO, resection of abdominopelvic mass | III | N | NR | - | - | 51 | NED | |
| 3 | LSH BSO | 6 | 250 | Y: Resection of pelvic mass appendectomy | II | CMT RT | NR | - | - | 36 | DWD | |
| Seidman et al., 2012[32] | 4 | LM | 6.2 | 139 | Y: Unspecified procedure | II | CMT | NR | - | - | 39 | NED |
| 5 | LM | NR | NR | Y: Unspecified procedure | NR | N | NR | - | - | 38 | NED | |
| 6 | LM | NR | NR | Y: Unspecified procedure | III: DPC | CMT | NR | - | - | 17 | DWD | |
| 7 | LM | NR | NR | Y: Unspecified procedure | NR | N | NR | - | - | 9 | NED | |
| 8 | LM | NR | NR | Y: Unspecified procedure | III: DPC | CMT | NR | - | - | 39 | NED | |
| 9 | LM | NR | NR | Y: Unspecified procedure | III: DPC | Arom/RT | NR | - | - | 27 | DWD | |
| 10 | LM | NR | NR | Y: Unspecified procedure | III: DPC | CMT | NR | - | - | 29 | DWD | |
| Bojahr et al., 2015[8] | 11 | LSH | NR | 567 | Y: Cervical stump extirpation | I | NR | N | - | 137 | NED | |
| 12 | LSH | NR | 1000 | Y: Cervical stump extirpation | I | NR | Y | Ab | 10 | 13 | DWD | |
| Graebe, et al., 2015[12] | 13 | TLH | NR | NR | Y: Unspecified procedure | IV: Sigmoid peritoneum | NR | Y | Ab | 3 | 5 | AWD |
| 14 | TLH | NR | NR | Y: Unspecified procedure | III: Adnexa, cervix omentum appendix | CMT | NR | - | - | AWD | ||
| 15 | TLH | NR | NR | N | I | NR | N | - | - | NED | ||
| Cusidó et al., 2015[33] | 17 | TLH | 6.5 | NR | N | NR | RT | Y | Ab | 6 | 36 | NED |
| 18 | LM | 5 | NR | Y: TH | NR | NR | Y | Ab | 26 | 27 | NED | |
| Cormio et al., 2015[10] | 19 | LM | 4 | NR | Y: TH BSO OM PND PW resection of trocar ports | Ia | CMT | N | - | - | 24 | NED |
| 20 | LM | 5 | NR | Y: TH BSO OM PND PW resection of trocar ports | Ia | CMT | N | - | - | 22 | NED | |
| 21 | LM | 6 | NR | Y: TH BSO OM PND PW resection of trocar ports | Ib | CMT | Y | Ab | 42 | 64 | DWD | |
| Nappi et al., 2008[34] | 22 | HM | 4 | NR | Y: TH BSO OM PND PW | I | CMT | N | - | - | 36 | NED |
| Chin et al., 2016[21] | 23 | LM | 5.7 | NR | Y: TH BSO | I | N | N | - | - | 100 | NED |
| 24 | LM | 9 | NR | Y: TH BSO | I | CCRT | Y | Ab | 11 | 51 | DWD | |
| Lee et al., 2016[19] | 25 | LM | NR | NR | Y: TH BSO OM PND PAND | I | NR | NR | - | - | AWD | |
| 26 | HM | NR | NR | Y: TH BSO PND | I | NR | NR | - | - | DWD | ||
| Zhang et al., 2016[14] | 27 | TLH | NR | 264 | N | IB | CMT | NR | - | - | 54 | NED |
| Tan et al., 2015[16] | 28 | LM | 14 | NR | NR | III | NR | Y | Ab | 32 | 34 | DWD |
| Oduyebo, et al., 2014[35] | 29 | LSH | NR | NR | Y: Trachelectomy, excision of port sites BSO, OM, peritoneal biopsies | I | RT | Y | NR | NR | 27 | NED |
| 30 | LSH | NR | NR | Y: Trachelectomy, BSO, PND, PW, peritoneal biopsies | I | N | N | - | - | 38 | NED | |
| 31 | LM | NR | NR | Y: TH BSO PND | I | CMT | N | - | 48.7 | NED | ||
| 32 | LM | NR | NR | Y: TH BSO OM PLD debulking | III: Omentum | RT | Y | NR | NR | 37.5 | DWD | |
| 33 | LSH | NR | NR | Y: Lysis adhesion, cervical biopsy, resection of port sites multiple biopsies | I | N | N | - | - | 20.2 | NED | |
| 34 | RA-TLH | NR | NR | NA | NR | CMT | Y | NR | NR | 15.3 | NED | |
| 35 | LSH | NR | NR | Y: BSO, debulking trachelectomy, OM | III: Cancer in all specimens | CMT | Y | NR | NR | 8.3 | NED | |
| Einstein et al., 2008[36] | 36 | LSH | NR | NR | Y: Trachelectomy and staging | I | NR | NR | - | - | 30 | NED |
| 37 | LM | NR | NR | Y: TAH BSO staging | III | NR | NR | - | - | 61 | NED | |
| 38 | SCH BSO Trachelectomy | NR | NR | Y: PLD and staging | III: Mesenteric nodule, pelvis vaginal cuff | NR | NR | - | - | 31 | AWD | |
| 39 | SCH BSO | NR | NR | Y: Trachelectomy with staging | I | NR | NR | - | - | 37 | NED | |
| 40 | SCH BSO | NR | NR | N | IV | NR | NR | - | - | 6 | AWD |
Ab: Abdomen, Arom: Aromatase inhibitor, AWD: Alive with disease, BSO: Bilateral salpingo-oophorectomy, CMT: Chemotherapy, DPC: Disseminated peritoneal carcinomatosis, DWD: Dead with disease, HM: Hysteroscopy myomectomy, LM: Laparoscopic myomectomy, LSH: Laparoscopic supracervical hysterectomy, N: No, NED: No evidence of disease, NR: Not reported, OM: Omentectomy, PAND: Paroaortic node dissection, PND: Pelvic node dissection, PW: Peritoneal washing, RA-TLH: Robotic-assisted total laparoscopic hysterectomy, RT: Radiotherapy, SCH: Supracervical hysterectomy, TH: Total hysterectomy, Y: Yes, RFS: Recurrence-free survival, TAH: Total abdominal hysterectomy